135
Participants
Start Date
June 17, 2019
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
NUC-7738
NUC-7738
Pembrolizumab
Pembrolizumab
NOT_YET_RECRUITING
Cambridge University Hospitals NHS Foundation Trust (Addenbrookes Hospital), Cambridge
RECRUITING
Edinburgh Cancer Centre, Western General Hospital, Edinburgh
RECRUITING
The Beatson West of Scotland Cancer Centre, Glasgow
NOT_YET_RECRUITING
University College London Hospital, London
NOT_YET_RECRUITING
The Royal Marsden NHS Foundation Trust, London
RECRUITING
The Christie NHS Foundation Trust, Manchester
RECRUITING
Freeman Hospital, Newcastle
RECRUITING
Oxford University Hospitals NHS Foundation Trust, Oxford
NOT_YET_RECRUITING
Lancashire Teaching Hospitals NHS Foundation Trust, Royal Preston Hospital, Preston
Lead Sponsor
NuCana plc
OTHER